Brunei vs Singapore: Average non-HDL cholesterol levels

Brunei
3.8
in 2018
Singapore
3.8
in 2018
Brunei rank
6th
Singapore rank
6th

Average non-HDL cholesterol levels over time

  • Brunei
  • Singapore
012345198019992018

How they compare

Brunei currently reports 3.8 against 3.8 in Singapore, a difference of 0.

Across all 39 years both countries report, Singapore has been ahead every year.

Brunei ranks 6th and Singapore ranks 6th of 191 countries.

Singapore has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Brunei Singapore Difference Ahead
1980s 3.76 4.53 0.77 Singapore
1990s 3.7 3.94 0.24 Singapore
2000s 3.77 3.8 0.03 Singapore
2010s 3.8 3.8 0

Averages of every year both report within each decade.

Frequently asked questions

Which has higher average non-hdl cholesterol levels, Brunei or Singapore?
Brunei, at 3.8 against 3.8 in Singapore as of 2018.
What is the difference in average non-hdl cholesterol levels between Brunei and Singapore?
0, with Brunei ahead.
How many years of comparable data are there for Brunei and Singapore?
39 years are reported by both, from 1980 to 2018.
How do Brunei and Singapore rank globally for average non-hdl cholesterol levels?
Brunei ranks 6th and Singapore ranks 6th of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.